What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (23 Viewers)

For sure, but that's true of any stock transaction.  Price staying high means people are buying at the ask, not the bid.

Also I would imagine most buyers are just hoping to resell after the stock moves closer to strike while most sellers are likely planning to hold to/near expiration.
Wouldn't buying at the ask be a sign that people remain pretty bearish? To get abnormal volume in an OTM option especially at an elevated premium usually means someone is betting big on a big fall. The premium looks juicy but usually when a trade seems too good to be true, it is. That or someone is just pissing money away. 

 
Anybody thinking about cashing DKNG gains?
A lot of Draft Kings upside will be due to what ones feelings are in regards to when people will feel safe traveling again.  If we are going to have an environment of fanless sports—where people will be spending more time at home and are still hesitant to travel—for any legitimately long period of time—I’d hold.   Fantasy football could be huge this year and their customer acquisition cost will be mind numbing low.  If you think that people will feel comfortable traveling fairly quickly—-I think you then consider taking profits.  I personally would hold—but solely based on my personal belief that travel won’t completely bounce back for a while. 

 
All Futures for US markets up 1% 

Gold up 1% Silver up 3%

Japan in recession

Powell issues warnings

Sheesh. That's a lot to digest.

 
Was reading something over the weekend about Saudi Arabia dumping another $7.7B in US Markets, mainly the larger S&P companies.  Everyone is flooding to US Markets it seems.

 
One has nothing to do with the other but I’ll say it anyway, Draftkings has a higher market cap than MGM, Wynn and CZR.  I mean they all have many locations and an online app too, plus you get real estate and actual gaming.  Guess you also get the fixed expenses to go with it as well.
TD lists a Market Cap of 9.1B.  I swear I saw 13B last week or the week before???  I'm not sure I believe they'll be worth their market cap for a while, but DKNG seems like a total hype play that will have a cult-like following.  Some big money guys in on it too.  

I'll keep holding.  And I get what you're saying.  I'll still play MGM too as I see some similarities but still different.   

 
Very likely none of my orders to sell puts (LUV, SPCE, C, PRU) will fill. Probably going to become a thought exercise, unfortunately. I’m not chasing in a rising market to write puts. 

 
bp1 said:
Hey, folks. Been around these boards for a while now and just decided to jump in the water. First off, thanks to everyone in this forum for your insight and knowledge (special shout-out to Chet and Todem, from my personal portfolio). 

I’ve got about $5k in holdings between apple, google, Facebook and Microsoft. I’ve had them for a while now and was wondering if you think they have more or less hit their apex in value/upside. I was thinking about selling them and using the cash to play some of the companies mentioned here (most specifically, from @Todem's list). Good idea to go after some more potential gains, or just stick with the ‘proven winners’ I have?

FYI - mid 40’s and the majority of my retirement will (hopefully) be funded via my 401(k), so I’m not completely relying on these stocks. Thanks, gang!!!


bp1 said:
I guess my thought was (and I should have mentioned it in my original post) — I’ve had these for a little while and have probably doubled my initial investment (give or take).  I recall a few folks mentioning that a good strategy could be to sell some of them to get my cost basis to $0 on what’s left. That’s where the question stemmed from — is there more upside value in some of @Todem's list (for example) versus a steady uptick in what I currently have? Thx. 
Morning, everyone.  Hope this doesn't break etiquette but I wanted to move this to the 'front' for some more of the weekday eyes to see it, just in case there are some nice opportunities today/this week.  Thanks.

 
I am awaiting your rooftop triple alarm to buy some TVIX.  
I may jump back in if dips to the 130's.  Pending Stim package has me a little nervous to start up another position right now.  I'm looking more at the Bulls right now.  :oldunsure:  

Maybe 120's...  Might his 130's today.  

 
Last edited by a moderator:
CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir

https://www.cytodyn.com/newsroom/press-releases/detail/432/cytodyn-to-prepare-a-phase-3-protocol-to-submit-to-the-fda

May 18, 2020 6:00am EDT

Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir

VANCOUVER, Washington, May 18, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it will be submitting a protocol to the U.S. Food and Drug Administration (FDA) for a factorial design trial to compare effectiveness of leronlimab versus remdesivir and in combination with remdesivir for the treatment of COVID-19. 

Leronlimab was administered to more than sixty patients with COVID-19 under emergency Investigational New Drug (eINDs) authorizations granted by the FDA.  Preliminary results from this patient population led to CytoDyn’s Phase 2b/3 clinical trial for 390 patients, which is randomized, placebo-controlled with 2:1 ratio (active drug to placebo ratio). CytoDyn has also been granted a Phase 2 randomized clinical trial study in the U.S. for a Phase 2 randomized clinical trial for mild-to-moderate COVID-19 population in the U.S. CytoDyn plans to update the public regarding current eIND results later this week.

“We believe the randomized head-to-head comparison of leronlimab to remdesivir and in combination will provide answers to the lingering question regarding effective treatment options for patients suffering from COVID-19. We look forward to working both in the United States and with potential international sites to help provide effective treatment options for COVID-19,” said Jacob Lalezari, M.D., Chief Science Officer of CytoDyn.   

“Unfortunately, COVID-19 remains a global public health challenge, and its economic impact continues to devastate the world economy.  With a second wave of potential cases threatening to surface in the fall and winter of 2020, it is more important than ever to be sure successful treatment options are available to protect the lives of patients. CytoDyn has assurance from its manufacturer that it will have available over 1 million vials this year and could ramp up production to 2-3 million vials this year alone,” said, Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn.

 
NERV up 10% pre-market today.

Doesn't change profit having sold puts ...but, further it gets from strike price the less chance it will drop below strike.

And the puts will be worth less should you want to cover early for a small profit and get out.

 
Not to damper these disconnected markets, but I fear we will see more and more of this:

https://m.specialtys.com/?amp=1

:(

“Specialty's Café & Bakery is closing after 33 years of business. Current market conditions attributed to COVID-19 and shelter-in-place policies have decimated company revenues. Our last day of operations will be Tuesday, May 19th, 2020”

 
Not to damper these disconnected markets, but I fear we will see more and more of this:

https://m.specialtys.com/?amp=1

:(

“Specialty's Café & Bakery is closing after 33 years of business. Current market conditions attributed to COVID-19 and shelter-in-place policies have decimated company revenues. Our last day of operations will be Tuesday, May 19th, 2020”
Damn - that was a solid chain, always packed at lunch 😢

 
Last edited by a moderator:
CYDY hit 3 Euros ($3.25 US) a bit ago in the German market.  It is currently $2.96 Euros ($3.21 US).  It has a bid price of $3.12 and an ask price of $3.15 in US premarket trading.

 
Last edited by a moderator:
Looks like a good day. Wish I was at 0% cash (only 15%, so not a bear) because damn, there appears to be no stopping this train. A little jealous of Moderna/Novavax the past few days but then I own a bunch of FLGT and premarket was up 27%. You can’t own them all but damn I am well past the February highs. It feels like we are walking on a wire here.

ETA: Looks like I’ll be lagging the market today. Too much AMZN and ZM that are definitely in the bear bucket now. Not going to complain about their performance but that’s part of why I’m worried about stocks. Everything is moving in lock step.

 
Last edited by a moderator:
Was gonna sell my MGM north of 15, and internet goes out while placing order.  Come back to find it at $14.72.  I just love Charter Communications.

 
I took my profits a few minutes ago from BLMN, CAKE, TAP,  and MGM.

I left my DFS alone.  Will look at that soon. 

Maybe I cut bait too early on everything, who knows, just feels weird things went up a lot.

 
:popcorn:

Everything going to the moon.

@Todem when are we jumping out of MGM/BLMN?
MGM I just put in a sell limit at $14.90 was on the phone with clients and that is the price of that...missed the open when it went above $15 we have plenty of time to hit $14.90 today....should fill IMO. 

I want $13 on BLMN so still holding.

 
Last edited by a moderator:
Sold at 118.  I might be missing something but thinking there will be an opportunity to get back in again near 100.
Saudi's bought 500M shares.  That'll give it a boost.  Agree with you though that there will be a better time to buy back in.  

 
Sold out of some of my more volatile positions (MGM, BLMN, DAL, UAL, CCL) to come back in lower later this week or next. 

 
Feels like a day to take some profits.  Markets be crazy.   :loco:
I mean it seems like a bit premature on the vaccine but that is actually something worth rallying on. A vaccine by year-end 2020 would be about best case scenario. For me, that is a thesis changing development. 

 
Out of all but MAR, BA, DFS.

I love this thread, I ignored it for years.. wtf was my problem?   :bag:

Averaging 28% on trades and holds since coming here a couple months back.

 
MGM I just put in a sell limit at $14.90 was on the phone with clients and that is the price of that...missed the open when it went above $15 we have plenty of time to hit $14.90 today....should fill IMO. 

I want $13 on BLMN so still holding.
Would it be foolish to try and hold out for more on MGM ($16 or so)?  :porked:  

 
Would it be foolish to try and hold out for more on MGM ($16 or so)?  :porked:  
We are not looking to be pigs on this one.....15ish has been it’s high range since the pandemic......then it pulls back...we buy again...rinse and repeat. Trade this stock....trade it.

 
Last edited by a moderator:

Users who are viewing this thread

Back
Top